Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Art Rousseau who wrote (6098)	3/23/1998 5:57:00 PM
From: RT	Read Replies (1) \| Respond to of 23519

<<I e-mailed this question to Nina over the weekend: " How much of the 'at risk' product is expected to be shipped to Europe this Quarter?" Her reply: " There will not be significant product shipped from the new plant to Europe during the first quarter. We have not disclosed the amount of product that is being produce 'at risk' but most of that product will be sent to the UK during the second quarter. >> Art, If my memory serves me correct Nina response was totally different to another SI member who said, all product at risk would be shipped Q1. This management teams refusal to acknowledge the amount of product produced at risk makes one suspicious. Their actions speak volumes. It's apparent they are trying to keep us investors uninformed. I hope the class action lawsuit brings justice to these clowns. RT